1.Research progress on the temporomandibular joint arthritis associated with juvenile idiopathic arthritis
Birong ZHONG ; Guilong ZHOU ; Shiping CHANG ; Yong YANG ; Zhongping SU ; Kezhen ZHAO ; Jinlong ZHAO ; Lei TIAN ; Qin MA
Journal of Practical Stomatology 2025;41(4):549-556
Juvenile idiopathic arthritis(JIA)is the most prevalent joint disease in childhood.The disease is defined as arthritis of unknown etiology,involving one or more joints,with onset before the age of 16 years and symptomatic duration of more than 6 weeks.Temporomandibular joint(TMJ)arthritis is a common manifestation of JIA,but it often develops insidiously.Failing to diag-nose and treat it promptly may lead to maxillofacial dysfunction and dentofacial deformity,and negatively affect the patient's quality of life.Therefore,early diagnosis and disease management of TMJ arthritis are crucial.This article reviews the occurrence of JIA-TMJ arthritis and its progress in clinical diagnosis and disease treatment in recent years,aiming to provide some reference for den-tists in the clinical diagnosis and treatment of JIA.
2.Research progress on the temporomandibular joint arthritis associated with juvenile idiopathic arthritis
Birong ZHONG ; Guilong ZHOU ; Shiping CHANG ; Yong YANG ; Zhongping SU ; Kezhen ZHAO ; Jinlong ZHAO ; Lei TIAN ; Qin MA
Journal of Practical Stomatology 2025;41(4):549-556
Juvenile idiopathic arthritis(JIA)is the most prevalent joint disease in childhood.The disease is defined as arthritis of unknown etiology,involving one or more joints,with onset before the age of 16 years and symptomatic duration of more than 6 weeks.Temporomandibular joint(TMJ)arthritis is a common manifestation of JIA,but it often develops insidiously.Failing to diag-nose and treat it promptly may lead to maxillofacial dysfunction and dentofacial deformity,and negatively affect the patient's quality of life.Therefore,early diagnosis and disease management of TMJ arthritis are crucial.This article reviews the occurrence of JIA-TMJ arthritis and its progress in clinical diagnosis and disease treatment in recent years,aiming to provide some reference for den-tists in the clinical diagnosis and treatment of JIA.
3.Dosimetric study of 6 MeV X-ray in different phantoms in a magnetic field
Birong HU ; Qianqian MENG ; Renming ZHONG
Chinese Journal of Radiation Oncology 2022;31(6):544-549
Objective:To evaluate the effects of orthogonal magnetic fields on the dose distribution of 6 MeV X-ray in a uniform water and heterogeneous phantoms.Methods:The Monte Carlo simulation software Gate v8.2 was used to investigate the dose distribution of X-ray beams of different field sizes in a uniform water phantom, water-air/bone-water layer phantom and" custom lung model" in the magnetic field strength of 0.0, 0.5, 1.0, 1.5, 3.0 T, respectively. The relationship between the intensity of magnetic field and the dose distribution of X-rays in the phantoms was analyzed.Results:The existence of a magnetic field would cause the X-ray to shorten the built-up area in the water phantom; when the field was 10 cm×10 cm, the maximum dose on the central axis could change by up to 56.22%(3.0 T). The transverse dose distribution of the radiation field in the direction of the vertical magnetic field shifted to one side by up to 43.64%(-44.55%). The average dose of the air layer in the water-air-water phantom could be reduced by 57.4%(3.0 T). In the water-bone-water phantom, the dose at the proximal end of the bone layer was decreased by 16.5%, whereas the dose at the distal end was increased by 22.6%(1.5 T). The dose change in each layer in the customed lung model was positively correlated with the magnetic field strength.Conclusion:The existence of the orthogonal magnetic field will cause the change of X-ray dose distribution on the built-up area and both sides of the radiation field in the phantoms, which is more obvious adjacent to the interface of heterogeneous phantom.
4.Study on the effect and mechanism of puerarin on the size of infarction in patients with acute myocardial infarction.
Li-zhong XIAO ; Zhi HUANG ; Shao-chun MA ; Zhaoyu ZEN ; Birong LUO ; Xiaoyun LIN ; Xin XU
Chinese Journal of Integrated Traditional and Western Medicine 2004;24(9):790-792
OBJECTIVETo observe the effect of puerarin on infarction size, fatty acids metabolism, inflammatory response and atherosclerotic plaque stability in patients with acute myocardial infarction (AMI).
METHODSSixty-one patients with AMI were randomly divided into two groups, the control group (n = 30) and the treated group (n = 31). All were treated with conventional treatment, but to the treated group, puerarin injection was given additionally by injecting 500 mg per day for 2 weeks. Before and after treatment, blood levels of free fatty acids (FFA), matrix metalloproteinases-9 (MMP-9) and C-reactive protein (CRP) were assayed, and the size of infarction was determined by Ideker QRS scoring method.
RESULTSBefore treatment, the size of infarction was positively correlated to the levels of FFA, MMP-9 and CRP (r = 0.43, 0.42 and 0.39, respectively, all P<0.01). As compared with those before treatment, after treatment, the three parameters lowered by 30%, 41% and 23%, respectively and the size of infarction significantly reduced in the treated group (P<0.01), while in the control group, no significant change was found (P>0.05).
CONCLUSIONPuerarin treatment could significantly reduce the size of infarction in patients with AMI, the mechanism is possibly related with its effects in lowering plasma levels of FFA, inhibiting inflammation and stabilizing atherosclerotic plaque.
Aged ; Biomarkers ; C-Reactive Protein ; metabolism ; Fatty Acids ; metabolism ; Female ; Humans ; Isoflavones ; therapeutic use ; Male ; Matrix Metalloproteinase 9 ; metabolism ; Middle Aged ; Myocardial Infarction ; drug therapy ; pathology ; Vasodilator Agents ; therapeutic use

Result Analysis
Print
Save
E-mail